Martin-Shkreli on topic

Martin Shkreli

Martin Shkreli is an American financial criminal and businessman. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016. In September 2015, Shkreli was widely criticized when Turing obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price by 5,455%. In 2017, Shkreli was charged and convicted in federal court on two counts of securities fraud and one count of conspiracy for activity unrelated to the Daraprim controversy. He was sentenced to seven years in prison and up to $7.4 million in fines. In the civil antitrust case Shkreli was fined a further $64.6 million to be repaid to victims. On May 18, 2022, he was released early from the low-security federal prison in Allenwood, Pennsylvania.

Pricing controversies
Chief executives in the pharmaceutical industry
Baruch College alumni
Hunter College High School alumni
American financial company founders
American financial analysts
American health care chief executives
American hedge fund managers
Criminals from New York City
American businesspeople convicted of crimes
American money managers
American chief executives of manufacturing companies
American people convicted of fraud
American entertainment industry businesspeople
American technology company founders
American chief executives of financial services companies
American art collectors
American investors
21st-century American criminals

License and Use

This Martin-Shkreli on net.photos image has x pixels (original) and is uploaded to . If you have a problem about intellectual property, child pornography or immature images with any of these pictures, please send report email to a webmaster at , to remove it from web.

Any questions about us or this search engine simply use our contact form